Viewing StudyNCT00354250



Ignite Creation Date: 2024-05-05 @ 4:58 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00354250
Status: COMPLETED
Last Update Posted: 2013-06-05
First Post: 2006-07-19

Brief Title: Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Stage IV Renal Cell Cancer
Recurrent Renal Cell Cancer
Stage III Renal Cell Cancer
Keywords: